Capital Advisory Group Advisory Services’s Integra LifeSciences IART Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-120	Closed	-$8K	–	307
2021 Q3	$8K	Hold	120	–	–	﹤0.01%	418
2021 Q2	$8K	Hold	120	–	–	﹤0.01%	418
2021 Q1	$8K	Hold	120	–	–	﹤0.01%	408
2020 Q4	$8K	Hold	120	–	–	﹤0.01%	388
2020 Q3	$6K	Hold	120	–	–	﹤0.01%	363
2020 Q2	$6K	Hold	120	–	–	﹤0.01%	354
2020 Q1	$5K	Buy	+120	New	+$6.3K	0.01%	307
2019 Q4	–	Sell	-120	Closed	-$7K	–	301
2019 Q3	$7K	Hold	120	–	–	﹤0.01%	318
2019 Q2	$7K	Hold	120	–	–	﹤0.01%	315
2019 Q1	$7K	Hold	120	–	–	0.01%	303
2018 Q4	$5K	Hold	120	–	–	﹤0.01%	302
2018 Q3	$8K	Hold	120	–	–	0.01%	260
2018 Q2	$8K	Hold	120	–	–	0.01%	253
2018 Q1	$7K	Buy	+120	New	+$6.29K	0.01%	255

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital Advisory Group Advisory Services's IART Position: Q4 2021 in Review

Capital Advisory Group Advisory Services sold out of Integra LifeSciences (IART) in Q4 2021, closing a stake of 120 shares — an estimated $8K sold.

Capital Advisory Group Advisory Services first reported a position in IART in Q1 2018 and held it in 14 quarters. The position peaked at $8K in Q3 2021. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

Capital Advisory Group Advisory Services reported no remaining Integra LifeSciences position as of Q4 2021 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 120 Integra LifeSciences shares in Q4 2021, an estimated $8K.
Capital Advisory Group Advisory Services first reported a position in Integra LifeSciences in Q1 2018 and held it in 14 quarters.
Capital Advisory Group Advisory Services's Integra LifeSciences position peaked at $8K in Q3 2021.
277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2021, filed 15 Feb 2022.